Key statistics
As of last trade, Philogen SpA (78Q:FRA) traded at 18.95, 16.62% above the 52 week low of 16.25 set on Feb 13, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 18.95 |
---|---|
High | 18.95 |
Low | 18.85 |
Bid | 18.85 |
Offer | 20.80 |
Previous close | 18.90 |
Average volume | 0.00 |
---|---|
Shares outstanding | 29.24m |
Free float | 10.97m |
P/E (TTM) | -- |
Market cap | 583.40m EUR |
EPS (TTM) | -0.7301 EUR |
Data delayed at least 15 minutes, as of Nov 22 2024 14:29 GMT.
More ▼
Announcements
- Philogen provides update on pre-planned interim analysis of the Phase III FIBROSARC trial investigating Onfekafusp alfa (L19TNF) in patients with first-line advanced or metastatic Soft Tissue Sarcoma
- Philogen S.p.A. announces receipt of the Good Manufacturing Practice Certificate for its new Production facility in Rosia (Siena, Italy) by Competent Authorities
- Philochem and Blue Earth Diagnostics Announce First Three Patients Imaged in Phase 1 Clinical Trial of 68Ga-OncoFAP (68Ga-OncoFAP-DOTAGA) for Diagnostic Imaging in Solid Tumors